ARTL Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ARTL shares is 6, representing 0.8% of the company's common stock.

TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in ARTL by -75.38% restricting it's holding to 4.86 thousand shares of worth nearly $2.00K. RENAISSANCE TECHNOLOGIES LLC also lessened -100% of the ARTL shares from its portfolio, reducing its holding to 0 shares of worth N/A. TWO SIGMA SECURITIES, LLC also shunned ARTL shares holding by -100% last quarter which brought its holding to 0 shares worth N/A.

As per its latest 13F filing, WELLS FARGO & COMPANY/MN increased its stake in ARTL by 8.85% in the last quarter. The institutional holder raised its holding to 283 shares having worth more than N/A. GEODE CAPITAL MANAGEMENT, LLC also added 11.46% more shares of ARTL to its portfolio, raising its holding to 187.07 thousand shares of worth $59.00K. UBS GROUP AG also increased its ARTL shares holding by 167.8% which brought its holding to 48.96 thousand shares worth $16.00K.

The insider with the most stakes in ARTL is LAPIN STEVEN B , President & C.O.O. at the company. Additionally, ARTL stock is highly held by Former Director CRAWFORD JOHN JOSEPH and director MATSUI CONNIE among others.

Company executives, directors, and other insiders own 0.83% percent of Artelo Biosciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ARTL insiders have sold stock, totaling 0 shares. Insiders that have sold shares include TATUM JAMES G, LAPIN STEVEN B, and CRAWFORD JOHN JOSEPH.

There have been 0 transaction(s) during the past 6-months in which Artelo Biosciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Artelo Biosciences, Inc. shares are held by insiders, which represents about 0.83% of ARTL stock.

ARTL President & C.O.O., LAPIN STEVEN B holds the largest portfolio of the company's shares. ARTL shares owned by LAPIN total nearly 195.67 thousand.

SNOWDEN CAPITAL ADVISORS LLC is the largest institutional owner in ARTL which holds 110 thousand shares worth $34.00K or 0.26% of the total ARTL shares outstanding followed by TOWER RESEARCH CAPITAL LLC (TRC) with ownership of 4.86 thousand shares representing 0.01% of the ARTL ownership. CREATIVE FINANCIAL DESIGNS INC /ADV is the third largest stakeholder with 1.08 thousand shares or 0% of the ownership worth more than N/A.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ARTL is concerned, it is a stock which is not optionable.

Number of ARTL shares short is 37.34K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 3.23M shares of ARTL are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ARTL has 3.20M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ARTL is 0.19.